Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
Primary Purpose
Cocaine-Related Disorders, Opioid-Related Disorders, Substance-Related Disorders
Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Buprenorphine
Sponsored by
About this trial
This is an interventional treatment trial for Cocaine-Related Disorders focused on measuring Opioid-Related Disorders
Eligibility Criteria
Please contact site for information.
Sites / Locations
- APT Residential Services Division
Outcomes
Primary Outcome Measures
Depression
Withdrawal symptoms
Opioid and cocaine use
Social and psychological functioning
AIDS risk behavior
Secondary Outcome Measures
Full Information
NCT ID
NCT00000216
First Posted
September 20, 1999
Last Updated
June 24, 2020
Sponsor
Yale University
Collaborators
National Institute on Drug Abuse (NIDA)
1. Study Identification
Unique Protocol Identification Number
NCT00000216
Brief Title
Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
Official Title
Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts
Study Type
Interventional
2. Study Status
Record Verification Date
June 2020
Overall Recruitment Status
Completed
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
January 2005 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Yale University
Collaborators
National Institute on Drug Abuse (NIDA)
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to compare the clinical efficacy of maintenance on low and high doses of buprenorphine with methadone for cocaine abusing opiate addicts.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cocaine-Related Disorders, Opioid-Related Disorders, Substance-Related Disorders
Keywords
Opioid-Related Disorders
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Enrollment
0 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Buprenorphine
Primary Outcome Measure Information:
Title
Depression
Title
Withdrawal symptoms
Title
Opioid and cocaine use
Title
Social and psychological functioning
Title
AIDS risk behavior
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Richard Schottenfeld, M.D.
Organizational Affiliation
Yale University
Official's Role
Principal Investigator
Facility Information:
Facility Name
APT Residential Services Division
City
New Haven
State/Province
Connecticut
ZIP/Postal Code
06519
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
9283506
Citation
Schottenfeld RS, Pakes JR, Oliveto A, Ziedonis D, Kosten TR. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry. 1997 Aug;54(8):713-20. doi: 10.1001/archpsyc.1997.01830200041006.
Results Reference
background
Learn more about this trial
Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
We'll reach out to this number within 24 hrs